ORAPI MAINTENANCE UK LIMITED

Here is the comprehensive financial health assessment for ORAPI MAINTENANCE UK LIMITED.

1. Financial Health Score: B

Explanation: The company is fundamentally healthy and profitable, showing modest growth in shareholder equity. However, it has been assigned a 'B' rather than an 'A' due to a noticeable tightening in short-term liquidity (working capital and cash reserves) driven by a heavy capital investment phase. Additionally, the presence of a significant environmental contingent liability acts as a pre-existing condition that requires careful monitoring.

2. Key Vital Signs

• Net Assets (Overall Body Strength): £1,773,864 (up from £1,717,752). The company's net worth is positive and growing, indicating a solid foundational structure.
• Working Capital (Energy Reserves): £944,762 (down from £1,495,284). While still positive, the drop of over £500,000 indicates that short-term obligations are eating into short-term resources at a faster rate.
• Cash Position (Blood Flow): £240,484 (down from £366,875). Cash reserves have dropped by roughly 34%. The patient's blood pressure is a bit lower this year, likely due to heavy exertion (capital expenditure).
• Trade Debtors (Digestion Rate): £1,166,358 (up from £991,308). An 18% increase in trade debtors suggests the company is waiting longer to collect money owed by customers, slowing down the conversion of sales into cash.
• Intra-Group Liabilities (External Life Support): Amounts owed to group undertakings jumped from £252,301 to £1,062,686. The company has received a significant cash transfusion from its French parent company (Groupe Paredes Orapi) to fund its operations and expansion.

3. Diagnosis

The financial data reveals a company in a transition or expansion phase. The patient has been exerting significant energy, evidenced by a massive £679,407 investment in tangible fixed assets (primarily plant and machinery, and other fixed assets). To fuel this growth without depleting its own reserves entirely, the company has relied heavily on intra-group financing from its parent company.

Symptoms of mild distress: The combination of declining cash, rising debtors, and a heavy reliance on group loans has caused working capital to contract. While the company is not insolvent, its short-term financial agility has been compromised. Furthermore, there is a latent genetic defect in the form of a contingent liability: Trichloroethene (TCE) contamination at the site. Although the directors believe this predates the company's tenancy, the Environment Agency permit surrender process and potential remediation costs represent an unpredictable risk that could stress the company's immune system if it flares up.

4. Recommendations

1. Restore Cash Flow and Working Capital: Focus on rebuilding cash reserves. The heavy capital expenditure phase appears to be concluding; subsequent profits should be directed toward replenishing the cash balance to ensure the business can handle unexpected shocks.
2. Accelerate Debtor Collection: Implement stricter credit control measures to reverse the buildup in trade debtors. Improving the "digestion rate" of sales into cash will naturally ease the working capital strain.
3. Formalise Intra-Group Debt: With over £1 million owed to the parent group, it is advisable to formalise the terms of this debt (e.g., repayment schedules, interest rates) to ensure clarity on long-term liabilities and avoid sudden calls on capital.
4. Proactive Environmental Risk Management: Continue to document and investigate the TCE contamination rigorously. Even if the company is a tenant and believes the contamination predates its occupancy, setting aside contingency plans or seeking legal indemnities from the landlord/previous occupiers is crucial to protect against potential regulatory or remediation costs.